WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 73.80
+0.70 (0.96%)
Sep 18, 2026, 1:30 PM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.32 billion as of September 17, 2026. Its market cap has increased by 0.55% in one year.
Market Cap
3.32B
Enterprise Value
4.11B
Revenue
1.21B
Ranking
n/a
PE Ratio
14.47
Stock Price
73.80
ChartMarket Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.32B, a decrease of -3.08%. That is a compound annual growth rate of -1.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 3.32B | -0.41% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 5.95B |
| Hi-Clearance | 5.72B |
| Apex Biotechnology | 2.99B |
| Bonraybio | 2.97B |
| Applied BioCode | 2.79B |
| A Plus Biotechnology | 2.50B |
| Wellell | 2.46B |
| Dynamic Medical Technologies | 2.15B |